Soft tissue augmentation using sculptra.

Gail Humble; Douglas Mest

doi:10.1055/s-2004-861758

Home/Archive/PubMed

PubMed · 15643584

Soft tissue augmentation using sculptra.

Gail Humble·Douglas Mest

View original source ↗Export metadata ↓

Abstract

Sculptra (poly-L-lactic acid) as of August 2004 has been approved by the U.S. Food and Drug Administration as the first injectable facial volumizer in the treatment of lipoatrophy. Lipoatrophy is often seen in HIV-positive patients and is felt to be multifactorial. This article reviews European and U.S. clinical study data and summarize treatment technique for both on label and off-label use.

Explore related subjects

Biocompatible Materials Collagen Humans Lactic Acid Lipodystrophy Microspheres Polyesters Polymers Prostheses and Implants Rhytidoplasty Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Gail Humble, Douglas Mest. 2004. Soft tissue augmentation using sculptra.. https://doi.org/10.1055/s-2004-861758

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Endothelial cell reaction on a biological material.

The successful clinical application of materials should involve detailed investigations on interaction between them and tissue with which they will contact. We examined herein the behavior of endothelial cells (ECs) on a collagen material, using histological and immunohistochemical methods. We used isolated human umbilical cord vein cells (HUVECs) identified by means of endothelial-specific antibodies. Cells were seeded in a standard density on a collagen membrane (Lycoll, Resorba, Nuernberg, Germany) and on gelatin-coated, control plastic surfaces, after two passages. These were then maintained for periods of 1, 7, or 14 days. The cells adhered, spread, and proliferated, and within 24 h started forming a subconfluent monolayer. We observed that the cultured cells expressed integrins (alpha5beta1 and alpha(v)beta3) and synthesized fibronectin. After 14 days, we could observe a confluent layer of ECs. We could conclude that the collagen material supported growth and attachment of endothelial cells. In addition, the attachment seemed to be most related to the fibronectin synthesized by the cells and to its highly expressed receptor (the alpha5beta1 integrin); even though this is not the only protein related to this adhesion, we observed that our cultured HUVECs did not synthesize vitronectin.

Biocompatible Materials↗

PubMed2006

Preparation of acrylic bone cements for vertebroplasty with bismuth salicylate as radiopaque agent.

One of the problems of percutaneous vertebroplasty attributed to the use of acrylic cements is related to the radiopacity of the formulation. The use of bismuth salicylate as the radiopaque agent is proposed in this work, taking into account the high radiopacity of organobismuth compounds used in dental applications and the possible analgesic effect of salicylic acid. Various cements formulated with this compound (some of them modified with polyethylene oxide) were examined. Setting parameters, mechanical properties, rheological behaviour, injectability, radiopacity and biocompatibility were studied for a variety of formulations, showing that the cement formulations containing bismuth salicylate have a higher radiopacity and better injection properties than commercial bone cement preparations and present good mechanical properties.

Biocompatible Materials↗

PubMed2006

Polyurethanes with radiopaque properties.

An aliphatic, commercially available, medical grade polyurethane, Tecoflex 80A was made radiopaque by coupling a 5-iodine-containing molecule, N-(2,6- diiodocarboxyphenyl)-3,4,5-triiodo benzamide (DCPTB) onto the polymer backbone. DCPTB was synthesized by coupling 4-amino-3,5-diiodobenzoic acid and 3,4,5-triiodobenzoic acid using dicyclohexyl carbodiimide. Radiopaque polyurethane thus obtained was characterized by IR, TGA, DSC and X-radiography. By optimizing the reaction conditions, it was possible to incorporate about 8% iodine in the polymer (wt/wt) to achieve radiopacity almost equivalent to that of a 2mm thick aluminium wedge. However, the products differed from the starting polymer in thermal characteristics. The starting polymer showed two endothermic transitions, the first one due to glass transition of the soft segment and the second one due to disruption of the hard segments. After modification, the second transition shifted to a lower temperature, while the first transition remained unaltered. Also, the modified polymers showed reduced thermal stability compared to the starting polymer. These observations could be explained on the basis of the reduced extent of intermolecular hydrogen bonding among the hard segments of the end product. Radiopaque polyurethanes are expected to have significant advantage over their non-radiopaque counterparts in many medical and related applications.

Biocompatible Materials↗